| Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study BM Biccard, TE Madiba, HL Kluyts, DM Munlemvo, FD Madzimbamuto, ... The Lancet 391 (10130), 1589-1598, 2018 | 507 | 2018 |
| High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma A Van den Berg, L Visser, S Poppema The American journal of pathology 154 (6), 1685-1691, 1999 | 445 | 1999 |
| Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. S Poppema, H Hollema, L Visser, H Vos The American journal of pathology 127 (3), 418, 1987 | 296 | 1987 |
| Keratinocyte‐derived growth factors play a role in the formation of hypertrophic scars FB Niessen, MP Andriessen, J Schalkwijk, L Visser, W Timens The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001 | 252 | 2001 |
| HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma M Niens, RF Jarrett, B Hepkema, IM Nolte, A Diepstra, M Platteel, ... Blood, The Journal of the American Society of Hematology 110 (9), 3310-3315, 2007 | 206 | 2007 |
| Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues E Maggio, A van den Berg, A Diepstra, J Kluiver, L Visser, S Poppema Annals of oncology 13, 52-56, 2002 | 196 | 2002 |
| Maternal and neonatal outcomes after caesarean delivery in the African Surgical Outcomes Study: a 7-day prospective observational cohort study D Bishop, RA Dyer, S Maswime, RN Rodseth, D Van Dyk, HL Kluyts, ... The Lancet Global Health 7 (4), e513-e522, 2019 | 185 | 2019 |
| Genome-wide association study of classical Hodgkin lymphoma and Epstein–Barr virus status–defined subgroups KY Urayama, RF Jarrett, H Hjalgrim, A Diepstra, Y Kamatani, A Chabrier, ... Journal of the National Cancer Institute 104 (3), 240-253, 2012 | 185 | 2012 |
| Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. W Timens, L Visser, S Poppema Laboratory Investigation; a Journal of Technical Methods and Pathology 54 (4 …, 1986 | 173 | 1986 |
| Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients MAJ van Eijndhoven, JM Zijlstra, NJ Groenewegen, EEE Drees, ... JCI insight 1 (19), 2016 | 161 | 2016 |
| Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases. SC Tang, L Visser, B Hepperle, J Hanson, S Poppema Journal of clinical oncology 12 (1), 149-154, 1994 | 155 | 1994 |
| The surgical safety checklist and patient outcomes after surgery: a prospective observational cohort study, systematic review and meta-analysis TEF Abbott, T Ahmad, MK Phull, AJ Fowler, R Hewson, BM Biccard, ... British journal of anaesthesia 120 (1), 146-155, 2018 | 153 | 2018 |
| Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes Y Ma, L Visser, H Roelofsen, M de Vries, A Diepstra, G van Imhoff, ... Blood, The Journal of the American Society of Hematology 111 (4), 2339-2346, 2008 | 151 | 2008 |
| Ectopic Expression of Human and Feline CD9 in a Human B Cell Line Confers β1 Integrin-dependent Motility on Fibronectin and Laminin Substrates and Enhanced Tyrosine … ARE Shaw, A Domanska, A Mak, A Gilchrist, K Dobler, L Visser, ... Journal of Biological Chemistry 270 (41), 24092-24099, 1995 | 147 | 1995 |
| Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin’s disease BM GL, S Poppema, BC HCM, T Wim, O Jan, V Lydia Blood 70 (1), 186-191, 1987 | 145 | 1987 |
| The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component Y Liu, A Sattarzadeh, A Diepstra, L Visser, A van den Berg Seminars in cancer biology 24, 15-22, 2014 | 142 | 2014 |
| miRNA analysis in B‐cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR‐150 and high BIC/miR‐155 expression M Wang, LP Tan, MK Dijkstra, K van Lom, JL Robertus, G Harms, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 141 | 2008 |
| Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery L Visser, CJ Zuurbier, FJ Hoek, BC Opmeer, E De Jonge, B De Mol, ... British journal of anaesthesia 95 (4), 448-457, 2005 | 139 | 2005 |
| Immune escape mechanisms in Hodgkin’s disease S Poppema, M Potters, L Visser, AM Van Den Berg Annals of Oncology 9, s21-s24, 1998 | 138 | 1998 |
| Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22 M Niens, L Visser, IM Nolte, G Van Der Steege, A Diepstra, P Cordano, ... British journal of haematology 140 (5), 527-536, 2008 | 136 | 2008 |
Anke van den BergProfessor of Molecular biology of malignant B cell lymphomas, University of Groningen, UniversityVerified email at umcg.nl
